None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Adults over 19 years of age 2) Diagnosis of nonorganic insomnia disorder (F51.0) of ICD-10 or sleep initiation and maintenance disorder by satisfying the criteria for diagnosis of nonorganic insomnia disorder of DSM-5 or the third edition of International Classification of Sleep Disorders , A person diagnosed with insomnia disorder (G47.0) 3) A person who satisfies 8 points or more on the Insomnia Disorder Severity Scale (ISI) 4) Those who have no difficulty in reading and writing Korean 5) Those who have no difficulty in using mobile applications using general-purpose equipment (smartphone or tablet PC, etc.) 6) A person who voluntarily decides to participate and agrees face-to-face to abide by the precautions after receiving and understanding sufficient explanations about this clinical trial 7) Android smartphone users
Exclusion criteria
Exclusion criteria: 1) DSM-5 other sleep arousal disorders other than insomnia (hypersomnia, narcolepsy, breathing-related Sleep disorder, circadian rhythm sleep arousal disorder, parasomnia) diagnosed 2) Those with insomnia due to physical illness or medications 3) A person with symptoms corresponding to a diagnosis of schizophrenia spectrum disorder, a diagnosis of bipolar disorder, or a person with symptoms corresponding to a major depressive episode at the time of basic evaluation 4) Has attempted suicide within the last 3 months, and committed suicide by a psychiatrist Those who are judged to be in the high-risk group 5) Has there been any other cognitive-behavioral therapy that has been newly started or ongoing within the last 3 months In this case, all other types of cognitive behavioral therapy, including insomnia, are included. 6) shift workers 7) Those with hearing impairment or cognitive impairment (e.g. dementia, etc.) 8) Those who have difficulty hearing, writing, and speaking Korean 9) Those who are contraindicated for sleep restriction treatment (pregnant women, students taking an exam, epilepsy, truck drivers or Long-distance bus drivers, heavy machinery drivers, etc., whose daytime sleepiness can have fatal consequences) 10) Those who have difficulty using general-purpose equipment (smartphone or tablet PC, etc.) 11) Those who are judged by the investigator to be unsuitable for participation in clinical trials due to other reasons 12) Those who have changed the type and dose of drugs that directly affect sleep within the last 1 month 13) pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean Insomnia Severity Scale (ISI) change in treatment group from pre-treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Mean Insomnia Severity Scale (ISI) from pre-treatment in the control group | — |
Countries
Korea, Republic of
Contacts
Yonsei University, Wonju Severance Christian Hospital